Login / Signup

Effects of a Safety Letter on Metoclopramide Use in Korea: An Interrupted Time-Series Analysis.

Hyungtae KimHae Sun Suh
Published in: Risk management and healthcare policy (2020)
Our results indicate that the changes in the number of prescriptions, dose, and the duration of prescription may have occurred as a result of the restrictions and recommendations in the safety letter. Further research is needed to optimize the use of metoclopramide and to identify the risk of adverse drug events since the safety letter was issued.
Keyphrases
  • adverse drug
  • electronic health record
  • clinical practice